Palvella Therapeutics (PVLA) Non-Current Assets (2013 - 2026)

Palvella Therapeutics (PVLA) posted quarterly Non-Current Assets of $528000.0 for Q1 2026, down 7.69% quarter-over-quarter from $572000.0 in Q4 2025.

Palvella Therapeutics (PVLA) Non-Current Assets (2013 - 2026) Analysis & Trends

Palvella Therapeutics (PVLA) has reported Non-Current Assets for 13 consecutive years, with $528000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non-Current Assets changed N/A year-over-year to $528000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 283.28% YoY), while the FY2025 annual figure was $572000.0, changed N/A from the prior year.
  • Non-Current Assets slipped to $528000.0 in Q1 2026 per PVLA's latest filing, from $572000.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $25.4 million in Q1 2022 and bottomed at $287000.0 in Q3 2023.
  • Historically, Non-Current Assets has averaged $15.1 million across 4 years, with a median of $21.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Non-Current Assets fell 7.81% — and 2023, when it slumped 98.61%.
  • Palvella Therapeutics' Non-Current Assets stood at $22.1 million in 2022, then slumped by 98.7% to $287000.0 in 2023, then soared by 99.3% to $572000.0 in 2025, then slipped by 7.69% to $528000.0 in 2026.
  • Business Quant data shows PVLA's Non-Current Assets at $528000.0 in Q1 2026, $572000.0 in Q4 2025, and $287000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.96 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 294.93 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.96 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3.76 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 18.06 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 938.60 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 468.65 Mn
10 Palvella Therapeutics 2.25 Bn 1.93 Bn - 482,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 482,000.00
Mar 31, 2026 528,000.00
Dec 31, 2025 572,000.00
Sep 30, 2023 287,000.00
Jun 30, 2023 21.07 Mn
Mar 31, 2023 21.75 Mn
Dec 31, 2022 22.07 Mn
Sep 30, 2022 20.60 Mn
Jun 30, 2022 23.41 Mn
Mar 31, 2022 25.37 Mn
Dec 31, 2021 25.94 Mn
Sep 30, 2021 26.54 Mn
Jun 30, 2021 27.36 Mn
Mar 31, 2021 27.51 Mn
Dec 31, 2020 29.29 Mn
Sep 30, 2020 27.07 Mn
Jun 30, 2020 25.76 Mn
Mar 31, 2020 25.40 Mn
Dec 31, 2019 26.08 Mn
Sep 30, 2019 18.78 Mn